Theravance Biopharma
TBPH
TBPH
104 hedge funds and large institutions have $1.1B invested in Theravance Biopharma in 2019 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 12 closing their positions.
Holders
104
Holders Change
+8
Holders Change %
+8.33%
% of All Funds
2.25%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
35
Reduced
21
Closed
12
Calls
$220K
Puts
$13.3M
Net Calls
-$13M
Net Calls Change
-$13.3M
Top Buyers
Top Sellers
| 1 |
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
|
$0 |
| 2 |
2
BlackRock
New York
|
$84.3M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$87.9M |
| 4 |
4
D.E. Shaw & Co
New York
|
$791K |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$112K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CAM
101
Cormorant Asset Management
Boston,
Massachusetts
| – | -$22.6M | -884,916 | Closed |
|
|
ARTA
102
A.R.T. Advisors
New York
| – | -$384K | -15,005 | Closed |
|
103
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$241K | -9,424 | Closed |
|
104
Prudential Financial
Newark,
New Jersey
| – | -$237K | -9,270 | Closed |
|
|
XK
105
Xact Kapitalforvaltning
Stockholm,
Sweden
| – | -$223K | -8,716 | Closed |
|
|
PA
106
Profund Advisors
Bethesda,
Maryland
| – | -$214K | -8,352 | Closed |
|
107
Principal Financial Group
Des Moines,
Iowa
| – | -$202K | -7,907 | Closed |
|
|
QT
108
Quantamental Technologies
White Plains,
New York
| – | -$102K | -4,000 | Closed |
|
|
FIA
109
FNY Investment Advisers
New York
| – | -$42K | -1,654 | Closed |
|
|
MWNA
110
Marshall Wace North America
New York
| – | -$31K | -1,215 | Closed |
|
|
PFC
111
Phocas Financial Corp
Alameda,
California
| – | -$3K | -114 | Closed |
|
|
IA
112
IFP Advisors
Tampa,
Florida
| – | -$1K | -57 | Closed |
|